Radiopharm Theranostics Limited Comprehensive Income Attributable To Noncontrolling Interests
Radiopharm Theranostics Limited (RADX) reported Comprehensive Income Attributable To Noncontrolling Interests of -$1.64 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests · last filed 2025-09-18
| Period end | Comprehensive Income Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2025-06-30 | -$1.64M 20-F · filed 2025-09-18 |
| 2024-06-30 | -$1.96M 20-F · filed 2025-09-18 |
| 2023-06-30 | -$162.53K 20-F · filed 2025-09-18 |